VITALE, MARIO
VITALE, MARIO
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth.
2001 Bifulco, M; Laezza, C; Portella, Giuseppe; Vitale, Mario; Orlando, P; De Petrocellis, L; Di, ; Marzo, V.
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth.
2001 Bifulco, M.; Laezza, C.; Portella, Giuseppe; Vitale, Mario; Orlando, P.; De Petrocellis, L.; Di Marzo, V.
Asandwich enzyme immunoassay for wheat gliadin.
1986 Troncone, R.; Vitale, Mario; Donatiello, A.; Farris, E.; Rossi, G.; Auricchio, S.
The different cardiac expression of the type 2 iodothyronine deiodinase gene between human and rat is related to the differential response of the Dio2 genes to Nkx-2.5 andGATA-4 transcription factors.
2003 Dentice, Monica; Morisco, Carmine; Vitale, Mario; Rossi, G.; Fenzi, G.; Salvatore, D.
Fibronectin is requiredto prevent thyroid cell apoptosis through an integrin-mediated adhesionmechanism.
1998 Vitale, Mario; Di Matola, T.; Fenzi, G.; Illario, Maddalena; Rossi, G.
revalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application.
2010 Guerra, A.; Sapio, M. R.; Marotta, V.; Campanile, E.; Moretti, M. I.; Deandrea, M.; Motta, M.; Limone, P. P.; Fenzi, Gianfranco; Rossi, Guido; Vitale, Mario
Limitations of Chromogranin A in clinical practice.
2012 Marotta, Vincenzo; Nuzzo, Vincenzo; Ferrara, Teresa; Zuccoli, A; Masone, M; Nocerino, L; DEL PRETE, Michela; Marciello, Francesca; Ramundo, Valeria; Lombardi, Gaetano; Vitale, Mario; Colao, Annamaria; Faggiano, Antongiulio
Growing thyroid nodules with benign histology and RET rearrangement.
2010 Marotta, V.; Guerra, Anna; Sapio, MARIA ROSARIA; Campanile, E.; Motta, M.; Fenzi, Gianfranco; Rossi, Guido; Vitale, Mario
Laminin receptors in differentiated thyroid tumors: restricted expression of the 67-Kilodalton laminin receptor in follicular carcinoma cells.
1999 Montuori, Nunzia; Müeller, F; DE RIU, S; Fenzi, Gianfranco; Sobel, Me; Rossi, Guido; Vitale, Mario
Are RET/PTC rearrangements in benign thyroid nodules of biological significance?
2010 Marotta, Vincenzo; Guerra, A.; Sapio, MARIA ROSARIA; Campanile, E.; Motta, M.; Fenzi, Gianfranco; Rossi, Guido; Vitale, Mario
Anandamide inhibits adhesion and migration of breast cancer cells.
2006 Grimaldi, C.; Pisanti, S.; Laezza, C.; Malfitano, A. M.; Santoro, A.; Vitale, Mario; Caruso, M. G.; Notarnicola, M.; Iacuzzo, I.; Portella, Giuseppe; Di Marzo, V.; Bifulco, Maurizio
Insulin stimulates fibroblast proliferation through calcium-calmodulin-dependent kinase II
2009 Monaco, Sara; Illario, Maddalena; Rusciano, M. R.; Gragnaniello, G.; DI SPIGNA, Gaetano; Leggiero, Eleonora; Pastore, Lucio; Fenzi, Gianfranco; Rossi, Guido; Vitale, Mario
High-doseintravenous corticosteroid therapy for Graves' ophthalmopathy. J EndocrinolInvest. 2001 Mar;24(3):152-8
2001 Macchia, Pe; Bagattini, M; Lupoli, Giovanni; Vitale, Mario; Vitale, G; Fenzi, G.
Prenyltransferase inhibitors induce apoptosis in proliferating thyroid cellsthrough a p53-independent CrmA-sensitive, and caspase-3-like protease-dependentmechanism.
1999 Vitale, Mario; Di Matola, T.; Rossi, G.; Laezza, C.; Fenzi, G.; Bifulco, M.
Cell-to-cellcontact modulates the expression of the beta 1 family of integrins in primarycultures of thyroid cells.
1995 Vitale, Mario; Casamassima, A.; Illario, Maddalena; Bassi, V.; Fenzi, G.; Rossi, G.
Inhibitors of Ras farnesylation revert the increased resistance tooxidative stress in K-Ras transformed NIH 3T3 cells.
1996 Santillo, Mariarosaria; Mondola, Paolo; Gioielli, A.; Serù, R.; Iossa, S.; Annella, T.; Vitale, Mario; Bifulco, M.
Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state
2008 Laezza, C; Fiorentino, L; Pisanti, S; Gazzerro, P; Caraglia, M; Portella, Giuseppe; Vitale, Mario; Bifulco, M.
Desethylamiodarone antagonizes the effect ofthyroid hormone at the molecular level.
2001 Bogazzi, F; Bartalena, L; Brogioni, S; Burelli, A; Raggi, F; Ultimieri, F; Cosci, C; Vitale, Mario; Fenzi, G; Martino, E.
Long-term interferon-alpha therapy does not affect sex hormones in males with chronic hepatitis C.
1997 Piazza, M.; Tosone, G.; Borgia, G.; Orlando, R.; Fenzi, G.; Vitale, Mario; Bloise, A.; Mariano, A.; Macchia, V.
Lovastatin-induced apoptosis in thyroid cells: involvement of cytochrome c andlamin B.
2001 Di Matola, T; D'Ascoli, F; Luongo, C; Bifulco, M; Rossi, G; Fenzi, G; Vitale, Mario
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. | 1.1 Articolo in rivista | 2001 | Bifulco, M; Laezza, C; Portella, Giuseppe; Vitale, Mario; Orlando, P; De Petrocellis, L; Di, ; Marzo, V. | |
| Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. | 1.1 Articolo in rivista | 2001 | Bifulco, M.; Laezza, C.; Portella, Giuseppe; Vitale, Mario; Orlando, P.; De Petrocellis, L.; Di Marzo, V. | |
| Asandwich enzyme immunoassay for wheat gliadin. | 1.1 Articolo in rivista | 1986 | Troncone, R.; Vitale, Mario; Donatiello, A.; Farris, E.; Rossi, G.; Auricchio, S. | |
| The different cardiac expression of the type 2 iodothyronine deiodinase gene between human and rat is related to the differential response of the Dio2 genes to Nkx-2.5 andGATA-4 transcription factors. | 1.1 Articolo in rivista | 2003 | Dentice, Monica; Morisco, Carmine; Vitale, Mario; Rossi, G.; Fenzi, G.; Salvatore, D. | |
| Fibronectin is requiredto prevent thyroid cell apoptosis through an integrin-mediated adhesionmechanism. | 1.1 Articolo in rivista | 1998 | Vitale, Mario; Di Matola, T.; Fenzi, G.; Illario, Maddalena; Rossi, G. | |
| revalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application. | 1.1 Articolo in rivista | 2010 | Guerra, A.; Sapio, M. R.; Marotta, V.; Campanile, E.; Moretti, M. I.; Deandrea, M.; Motta, M.; Limone, P. P.; Fenzi, Gianfranco; Rossi, Guido; Vitale, Mario | |
| Limitations of Chromogranin A in clinical practice. | 1.1 Articolo in rivista | 2012 | Marotta, Vincenzo; Nuzzo, Vincenzo; Ferrara, Teresa; Zuccoli, A; Masone, M; Nocerino, L; DEL PRETE, Michela; Marciello, Francesca; Ramundo, Valeria; Lombardi, Gaetano; Vitale, Mario; Colao, Annamaria; Faggiano, Antongiulio | |
| Growing thyroid nodules with benign histology and RET rearrangement. | 1.1 Articolo in rivista | 2010 | Marotta, V.; Guerra, Anna; Sapio, MARIA ROSARIA; Campanile, E.; Motta, M.; Fenzi, Gianfranco; Rossi, Guido; Vitale, Mario | |
| Laminin receptors in differentiated thyroid tumors: restricted expression of the 67-Kilodalton laminin receptor in follicular carcinoma cells. | 1.1 Articolo in rivista | 1999 | Montuori, Nunzia; Müeller, F; DE RIU, S; Fenzi, Gianfranco; Sobel, Me; Rossi, Guido; Vitale, Mario | |
| Are RET/PTC rearrangements in benign thyroid nodules of biological significance? | 1.1 Articolo in rivista | 2010 | Marotta, Vincenzo; Guerra, A.; Sapio, MARIA ROSARIA; Campanile, E.; Motta, M.; Fenzi, Gianfranco; Rossi, Guido; Vitale, Mario | |
| Anandamide inhibits adhesion and migration of breast cancer cells. | 1.1 Articolo in rivista | 2006 | Grimaldi, C.; Pisanti, S.; Laezza, C.; Malfitano, A. M.; Santoro, A.; Vitale, Mario; Caruso, M. G.; Notarnicola, M.; Iacuzzo, I.; Portella, Giuseppe; Di Marzo, V.; Bifulco, Maurizio | |
| Insulin stimulates fibroblast proliferation through calcium-calmodulin-dependent kinase II | 1.1 Articolo in rivista | 2009 | Monaco, Sara; Illario, Maddalena; Rusciano, M. R.; Gragnaniello, G.; DI SPIGNA, Gaetano; Leggiero, Eleonora; Pastore, Lucio; Fenzi, Gianfranco; Rossi, Guido; Vitale, Mario | |
| High-doseintravenous corticosteroid therapy for Graves' ophthalmopathy. J EndocrinolInvest. 2001 Mar;24(3):152-8 | 1.1 Articolo in rivista | 2001 | Macchia, Pe; Bagattini, M; Lupoli, Giovanni; Vitale, Mario; Vitale, G; Fenzi, G. | |
| Prenyltransferase inhibitors induce apoptosis in proliferating thyroid cellsthrough a p53-independent CrmA-sensitive, and caspase-3-like protease-dependentmechanism. | 1.1 Articolo in rivista | 1999 | Vitale, Mario; Di Matola, T.; Rossi, G.; Laezza, C.; Fenzi, G.; Bifulco, M. | |
| Cell-to-cellcontact modulates the expression of the beta 1 family of integrins in primarycultures of thyroid cells. | 1.1 Articolo in rivista | 1995 | Vitale, Mario; Casamassima, A.; Illario, Maddalena; Bassi, V.; Fenzi, G.; Rossi, G. | |
| Inhibitors of Ras farnesylation revert the increased resistance tooxidative stress in K-Ras transformed NIH 3T3 cells. | 1.1 Articolo in rivista | 1996 | Santillo, Mariarosaria; Mondola, Paolo; Gioielli, A.; Serù, R.; Iossa, S.; Annella, T.; Vitale, Mario; Bifulco, M. | |
| Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state | 1.1 Articolo in rivista | 2008 | Laezza, C; Fiorentino, L; Pisanti, S; Gazzerro, P; Caraglia, M; Portella, Giuseppe; Vitale, Mario; Bifulco, M. | |
| Desethylamiodarone antagonizes the effect ofthyroid hormone at the molecular level. | 1.1 Articolo in rivista | 2001 | Bogazzi, F; Bartalena, L; Brogioni, S; Burelli, A; Raggi, F; Ultimieri, F; Cosci, C; Vitale, Mario; Fenzi, G; Martino, E. | |
| Long-term interferon-alpha therapy does not affect sex hormones in males with chronic hepatitis C. | 1.1 Articolo in rivista | 1997 | Piazza, M.; Tosone, G.; Borgia, G.; Orlando, R.; Fenzi, G.; Vitale, Mario; Bloise, A.; Mariano, A.; Macchia, V. | |
| Lovastatin-induced apoptosis in thyroid cells: involvement of cytochrome c andlamin B. | 1.1 Articolo in rivista | 2001 | Di Matola, T; D'Ascoli, F; Luongo, C; Bifulco, M; Rossi, G; Fenzi, G; Vitale, Mario |